Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
849.00    -0.50 (-0.06%)
Bid:
845.50
Ask:
848.00
Spread: 2.50 (0.296%)
Market Cap: £977.83m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Total Voting Rights

1 May 2024 12:00

RNS Number : 8472M
Kainos Group plc
01 May 2024
 

01 May 2024

Kainos Group plc

("Kainos" or the "Company") 

Total Voting Rights

 

Pursuant to DTR 5.6.1 the Company announces that as at 01 May 2024, the total number of ordinary shares in issue now stands at 125,820,677 each with voting rights. There are no shares held in treasury.

 

The above figure 125,820,677 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Kainos Group plc Legal Entity Identifier: 213800H2PQMIF3OVZY47 

Classification: 2.5 - Total number of voting rights and capital

 

 

Ends

 

For further information, please contact:

 

Kainos via FTI Consulting LLP

Russell Sloan, Chief Executive Officer

Richard McCann, Chief Financial Officer

 

Investec Bank plc +44 20 7597 5970

Patrick Robb / Ben Griffiths

 

FTI Consulting LLP +44 20 3727 1000

Matt Dixon / Dwight Burden / Kwaku Aning

 

About Kainos

Kainos Group plc is a UK-headquartered IT provider with expertise across three divisions - Digital Services, Workday Services, and Workday Products.

 

Our Digital Services division develops and supports custom digital service platforms for public sector, commercial, and healthcare customers. Our solutions transform the delivery of these services, ensuring they are secure, accessible, and cost-effective, and provide better outcomes for users. 

 

Our Workday Services division specialises in the deployment of Workday Inc.'s Finance, HR and Planning products to leading organisations across Europe and North America. We are one of Workday's most respected partners, experienced in complex deployment and trusted by our customers to launch, test, expand, and support their Workday systems.

 

Our Workday Products division develops products that complement Workday. Our Smart product suite, including Smart Test (for automated testing), Smart Audit (for compliance monitoring), and Smart Shield (for data masking), are used by more than 400 customers globally to safeguard their Workday systems.

 

Our people are central to our success. We employ more than 3,100 people in 23 countries across Europe, Asia and the Americas. 

 

We are listed on the London Stock Exchange (LSE: KNOS) and you can discover more about us at www.kainos.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRBFLFBZELEBBK
Date   Source Headline
3rd Sep 20207:00 amRNSKainos Trading Update
1st Sep 20207:00 amRNSTotal Voting Rights
27th Aug 20204:27 pmRNSBoard Committee Membership
25th Aug 20204:46 pmRNSHolding(s) in Company
19th Aug 202010:10 amRNSNotice of AGM
5th Aug 20201:13 pmRNSDirector/PDMR Shareholding
31st Jul 202011:29 amRNSTotal Voting Rights
31st Jul 20208:39 amRNSAnnual Report 2020
27th Jul 20207:00 amRNSTrading Update and Special Dividend
3rd Jul 20201:56 pmRNSDirector/PDMR Shareholding
1st Jul 202012:20 pmRNSTotal Voting Rights
30th Jun 20205:10 pmRNSCorrection: Director/PDMR Shareholding
30th Jun 20201:59 pmRNSDirector/PDMR Shareholding
9th Jun 202011:39 amRNSDirector Declaration
9th Jun 20208:59 amRNSDirector/PDMR Shareholding
1st Jun 202011:51 amRNSTotal Voting Rights
28th May 20205:00 pmRNSHolding(s) in Company
26th May 20207:00 amRNSPreliminary results for year ended 31 March 2020
1st May 20209:19 amRNSTotal Voting Rights
23rd Apr 202012:07 pmRNSSecond Price Monitoring Extn
23rd Apr 202012:02 pmRNSPrice Monitoring Extension
16th Apr 20207:00 amRNSTrading Update
14th Apr 20204:37 pmRNSPrice Monitoring Extension
1st Apr 20201:09 pmRNSTotal Voting Rights
2nd Mar 20207:00 amRNSKainos acquires IntuitiveTEK LLC
31st Jan 202011:28 amRNSTotal Voting Rights
6th Jan 20209:41 amRNSTotal Voting Rights
19th Dec 20195:46 pmRNSHolding(s) in Company
9th Dec 20192:37 pmRNSCORRECTION: Director/PDMR Shareholding
6th Dec 20193:29 pmRNSHolding(s) in Company
6th Dec 20193:29 pmRNSDirector/PDMR Shareholding
5th Dec 201912:02 pmRNSPrice Monitoring Extension
3rd Dec 20193:42 pmRNSDirector/PDMR Shareholding
29th Nov 20194:00 pmRNSHolding(s) in Company
29th Nov 20193:54 pmRNSDirector/PDMR Shareholding
29th Nov 201911:00 amRNSTotal Voting Rights
28th Nov 201910:42 amRNSAppointment of Non-Executive Director
20th Nov 201912:07 pmRNSSecond Price Monitoring Extn
20th Nov 201912:02 pmRNSPrice Monitoring Extension
11th Nov 20197:01 amRNSKainos Acquires Formulate and Implexa
11th Nov 20197:00 amRNSInterim Results
1st Nov 201911:15 amRNSTotal Voting Rights
30th Sep 20193:14 pmRNSTotal Voting Rights
26th Sep 20191:15 pmRNSChairman Appointment & Committee Membership Change
26th Sep 201912:00 pmRNSResults of Annual General Meeting
5th Sep 20195:31 pmRNSHolding(s) in Company
4th Sep 20197:00 amRNSTrading Update
3rd Sep 20193:44 pmRNSHolding(s) in Company
2nd Sep 201910:50 amRNSTotal Voting Rights
21st Aug 20191:40 pmRNSNotice of Annual General Meeting 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.